MedPageToday -- The investigational drug lasofoxifene markedly reduced the risk of incident breast cancer in post-menopausal women with osteoporosis, researchers reported.
MedPageToday -- The investigational drug lasofoxifene markedly reduced the risk of incident breast cancer in post-menopausal women with osteoporosis, researchers reported.
